Form 8-K - Current report:
SEC Accession No. 0001654954-21-010093
Filing Date
2021-09-15
Accepted
2021-09-15 06:35:50
Documents
14
Period of Report
2021-09-14
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT cdxc_8k.htm   iXBRL 8-K 21893
  Complete submission text file 0001654954-21-010093.txt   145705

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cdcx-20210914.xsd EX-101.SCH 5595
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cdcx-20210914_cal.xml EX-101.CAL 890
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cdcx-20210914_def.xml EX-101.DEF 2097
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cdcx-20210914_lab.xml EX-101.LAB 14803
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cdcx-20210914_pre.xml EX-101.PRE 9411
7 EXTRACTED XBRL INSTANCE DOCUMENT cdxc_8k_htm.xml XML 3611
Mailing Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024
Business Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024 310-388-6706
ChromaDex Corp. (Filer) CIK: 0001386570 (see all company filings)

EIN.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37752 | Film No.: 211254192
SIC: 2833 Medicinal Chemicals & Botanical Products